Buscar resultados de ensayos clínicos

Patrocinado por

Acute Promyelocytic Leukemia - 35 Studies Found

Estado Estudiar
Completed Nombre del estudio: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Condición: Acute Promyelocytic Leukemia
Fecha: 2007-08-21
Intervenciones: Drug: Tamibarotene For induction therapy, tamibarotene will be self-administered via tablets on an outpa
Recruiting Nombre del estudio: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Condición:
  • Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA
  • Drug: Arsenic Trioxide Given I
Terminated Nombre del estudio: ASCT for Relapsed APL After Molecular Remission
Condición:
  • Acute Promyelocytic Leukemia
  • Relapse

Fecha: 2009-05-21
Intervenciones: Procedure: autologous hematopoietic cell transplantation A
Completed Nombre del estudio: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Condición:
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Promye
    Fecha: 1999-11-01
    Intervenciones:
    • Drug: tretinoin Given orally
Completed Nombre del estudio: Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condición: Acute Promyelocytic Leukemia
Fecha: 2010-10-20
Intervenciones:
  • Drug: ATRA see the protocol
Completed Nombre del estudio: National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Condición:
  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL

Fecha: 2014-07-11
Intervenciones: Other: observational
Enrolling by invitation Nombre del estudio: A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Condición: Childhood Acute Promyelocytic Leukemia
Fecha: 2014-02-08
Intervenciones:
  • Drug: ATO Given IV

Recruiting Nombre del estudio: Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Condición: Leukemia
Fecha: 2011-08-02
Intervenciones:
  • Drug: ATRA 45 mg/m2 daily by m
Completed Nombre del estudio: Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condición: Leukemia
Fecha: 2010-08-18
Intervenciones: Drug: Ara-c Drug: ATRA 25mg/m2 day until complete remissio
Completed Nombre del estudio: Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
Condición: Leukemia, Myelocytic, Acute
Fecha: 2009-08-18
Intervenciones:
  • Drug: gemtuzumab ozogamicin 2

<<< Previous | Next >>>